Stereotaxis, Inc. (STXS)
2.345
-0.02
(-1.05%)
USD |
NYAM |
Dec 15, 16:00
2.345
0.00 (0.00%)
After-Hours: 18:30
Stereotaxis Research and Development Expense (Quarterly): 2.546M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Electromed, Inc. | 0.241M |
| IRIDEX Corp. | 0.972M |
| Axogen, Inc. | 7.565M |
| Phibro Animal Health Corp. | -- |
| Myomo, Inc. | 1.528M |